News from viiv healthcare A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle.

Latest

Jun 13, 2014, 18:06 ET ViiV Healthcare y Janssen investigarán el régimen de tableta única para el tratamiento de mantenimiento del VIH-1

ViiV Healthcare ha anunciado hoy que han entrado en un acuerdo con Janssen R&D Ireland Ltd (Janssen) para el desarrollo y comercialización de una...


Jun 12, 2014, 06:17 ET ViiV Healthcare announces new collaboration with Janssen to investigate single-tablet regimen for maintenance treatment of HIV-1

ViiV Healthcare today announced that they have entered into an agreement with Janssen R&D Ireland Ltd (Janssen) for the development and...


Jun 10, 2014, 07:00 ET Una encuesta nacional identifica posibles obstáculos para el tratamiento contra el VIH en los EE. UU.

ViiV Healthcare anunció hoy nuevos datos de una encuesta que proporciona importantes detalles que pueden ayudar a explicar el motivo por el cual los...


Jun 10, 2014, 07:00 ET National Survey Identifies Potential Barriers to HIV Treatment Use in U.S.

ViiV Healthcare today announced new survey data that provide important insights that may help explain why HIV treatment rates remain low in the...


Apr 01, 2014, 02:30 ET ViiV Healthcare announces new initiatives to improve access to dolutegravir: licence to the Medicines Patent Pool

ViiV Healthcare today announced new collaborations with the goal of increasing access to its HIV medicine, dolutegravir (marketed under the name...


Mar 19, 2014, 09:45 ET ViiV Healthcare Announces Next Round of the Positive Action Southern Initiative to Support Linkages to HIV/AIDS Care and Treatment Adherence

ViiV Healthcare today issued a new request for letters of interest (LOIs) for the sixth round of its Positive Action Southern Initiative – inviting...


Jan 21, 2014, 06:52 ET ViiV Healthcare's new HIV medicine Tivicay™ (dolutegravir) is approved in Europe

ViiV Healthcare today announced that the European Commission has approved Tivicay™ (dolutegravir), an integrase inhibitor, for use in combination...


Nov 22, 2013, 09:00 ET Tivicay® (dolutegravir) receives positive CHMP opinion in Europe for the treatment of HIV

ViiV Healthcare today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has issued a...


Oct 22, 2013, 12:53 ET ViiV Healthcare announces US regulatory submission for a single-tablet regimen combining dolutegravir with abacavir and lamivudine for people living with HIV

ViiV Healthcare today announced the submission of a regulatory application in the United States for its investigational single-tablet regimen (STR)...


Sep 12, 2013, 06:22 ET ViiV Healthcare Presents Positive Data from Phase IIIb/IV Study of Dolutegravir vs Darunavir in Treatment-Naive Adults with HIV-1

ViiV Healthcare today announced initial results from the Phase IIIb/IV FLAMINGO (ING114915) study. This open-label study, for the first time,...


Sep 04, 2013, 09:00 ET ViiV Healthcare Expands HIV/AIDS Community Support in Hard-Hit Southern U.S.

ViiV Healthcare announced today the first Positive Action Southern Initiative (PASI) grant awardees in Texas and Virginia and seven grant awards to...


Aug 14, 2013, 07:16 ET ViiV Healthcare anuncia la aprobación de Tivicay® (dolutegravir) en EE. UU. para el tratamiento del VIH-1

ViiV Healthcare tiene el gusto de anunciar hoy que la Administración de Drogas y Alimentos (Food and Drug Administration, FDA) de los EE. UU. ha...


Nov 08, 2012, 03:30 ET ViiV Healthcare commits nearly £4M in Positive Action for Children Fund grants for programmes focused on alleviating burden of HIV on women and children

ViiV Healthcare announced today that it has awarded nearly £4 million to 99 projects in 26 countries through its Positive Action for Children Fund...


Jul 18, 2012, 04:00 ET ViiV Healthcare Expands Commitment to Addressing Gaps in Paediatric HIV Research, Care and Treatment

ViiV Healthcare today announced a broad range of groundbreaking initiatives as part of its ongoing commitment to address the gaps in care and...


Oct 13, 2011, 09:00 ET ViiV Healthcare's Positive Action for Children Fund Announces 16 New Grantees for the Year 2011/2012

ViiV Healthcare announced today that it has awarded approximately 3.9 million pounds Sterling to 16 organisations in eight countries, through its...


Oct 12, 2011, 19:07 ET 'ViiV Healthcare Effect' haucht den positiven Aktionspartnerschaften von ViiV Healthcare Leben ein

- Persönliche Geschichten, Lebenserfahrungen und Kooperationen auf neuer Website vorgestellt WAS: Der ViiV Healthcare Effect ...


Oct 12, 2011, 18:55 ET 'ViiV Healthcare Effect' proporciona asociaciones de acción positivas para la vida de ViiV Healthcare

- La nueva página web muestra las historias personales, experiencias de la vida real y colaboraciones QUÉ: ViiV Healthcare Effect...


Oct 12, 2011, 13:47 ET 'ViiV Healthcare Effect' donne vie aux partenariats Action positive de ViiV Healthcare

- Un nouveau site Web présente des histoires personnelles, des expériences dans la vraie vie et des collaborations SUJET : Le ViiV...


Oct 12, 2011, 05:00 ET 'ViiV Healthcare Effect' Brings ViiV Healthcare's Positive Action Partnerships to Life

WHAT: The ViiV Healthcare Effect (www.ViiVHealthcareEffect.com) introduces our company's approach to partnerships in a unique and personal way. Today ...


Oct 12, 2011, 05:00 ET 'ViiV Healthcare Effect' hace realidad las asociaciones para la acción positiva de ViiV Healthcare

QUÉ: ViiV Healthcare Effect (www.ViiVHealthcareEffect.com) presenta el enfoque de nuestra compañía a las asociaciones de un modo exclusivo y personal....


Oct 12, 2011, 01:58 ET "ViiV Healthcare Effect"dá vida a parcerias da Ação Positiva da ViiV Healthcare

O QUE: O ViiV Healthcare Effect (www.ViiVHealthcareEffect.com) apresenta a abordagem de nossa empresa a parcerias, de uma forma única e pessoal....


Oct 11, 2011, 09:00 ET ViiV Healthcare Starts Phase III Clinical Programme of Celsentri/Selzentry® (maraviroc) versus Truvada® (tenofovir + FTC), in combination with a Protease Inhibitor in people living with HIV

ViiV Healthcare announces the start of the Phase III MODERN Study [Maraviroc Once daily with Darunavir Enhanced by Ritonavir in a Novel regimen],...


Oct 12, 2010, 09:00 ET ViiV Healthcare Acts to Improve Access to HIV Medicines in United States for Those Most in Need

ViiV Healthcare will expand its Patient Assistance Program effective January 1, 2011 and continue its Patient Savings Card program to help maintain...


Sep 09, 2010, 10:00 ET ViiV Healthcare Awards Southern Initiative Grants to Reduce HIV Disparities Among African Americans and Latinos

ViiV Healthcare today announced the grant awardees of the Positive Action Southern Initiative, focused on supporting African American and Latino...


Jul 06, 2010, 02:43 ET ViiV Healthcare Announces Positive Action U.S. Southern Initiative, an Innovative Community Support Program to Fight HIV/AIDS

ViiV Healthcare today announced the launch of Positive Action U.S. Southern Initiative, a collaborative, community-focused program designed to...